KING ANDREW JAMES (Head of Renal Discovery) sold 22.7% of their position (5K shares) of CHINOOK THERAPEUTICS, INC. on the open market
Open‑market sale worth $116.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/5/2023ACC: 0001209191-23-023351
Officer· Head of Renal Discovery
Since Oct 2020
-5K
Net shares
Net seller
$116.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.50K acquired · 7.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.50K
Price / share
$0.35
Trade value
$875.00
% of position
12.8%
4/3/2023
19.49K→21.99K
Common Stock
Direct
Shares
−5K
Price / share
$23.34
Trade value
$116.72K
% of position
22.7%
4/3/2023
21.99K→16.99K
Total
Net shares
−2.50K
Net value
-$115.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/3/2023 | M · Option Exercise | +2.50K | $0.35 | $875.00 | 12.8% | 19.49K | 21.99K |
| Common Stock Direct | 4/3/2023 | S · Sale | −5K | $23.34 | $116.72K | 22.7% | 21.99K | 16.99K |
| Total | −2.50K | -$115.84K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
2.50K shares
Shares
−2.50K
Strike price
0.35
Held after
43.05K
Exercisable
—
4/3/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock2.50K shares | 4/3/2023 | M · Option Exercise | −2.50K | 0.35 | — | 43.05K |